Pseudo-hypoparathyroidism: New diagnostic and therapeutic approaches;Pseudo-hypoparathyoidies: Nouvelles approches diagnostiques et therapeutiques

Archives de Pediatrie

Volumn 4, Issue SUPPL. 2, 1997, Pages

  Carel, J C ^a   Garabedian M ^a   Mallet, E ^b   Chaussain, J L ^a  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b HÔPITAL CHARLES NICOLLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; GUANINE NUCLEOTIDE BINDING PROTEIN; PARATHYROID HORMONE; VITAMIN D; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

CHILD; CONFERENCE PAPER; HUMAN; HYPOCALCEMIA; PRACTICE GUIDELINE; PSEUDOHYPOPARATHYROIDISM; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

CHILD; DIAGNOSIS, DIFFERENTIAL; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; GTP-BINDING PROTEINS; HUMANS; PSEUDOHYPOPARATHYROIDISM;

EID: 0030635060     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(97)86469-X     Document Type: Conference Paper

References (35)

1. Spiegel AM, Shenker A, Weinstein LS. Receptor-effector coupling by G-proteins: implications for normal and abnormal signal transduction. Endocrine Rev 1992;13:536-65
2. Pollak MR, Brown EM, Chou YHW et al. Mutations in the human Ca2t-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 1993; 75:1297-303
3. Clapham DE. Mutations in G protein-linked receptors: novel insights on disease. Cell 1993;75:1237-9
4. Simon MI, Strathmann MP, Gautam N. Diversity of G-proteins in signal transduction. Science 1991;252:802-8
5. Savarese TM, Fraser CM. In vitro mutagenesis and the search for structure-function relationships among G-protein coupled receptors. Biochem J 1992;283:1-19
6. Albright F, Burnett CH, Smith PH, Parson W. Pseudo-hypoparathyroidism, an example of « Seambright-Bantam syndrome »: report of three cases. Endocrinology 1942;30:922-32
7. Spiegel AM. Pseudohypoparathyroidism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited diseases. New York: McGraw-Hill, 1989:2013-27
8. Levine MA, Tjin-Shing J, Mauseth RS, Downs RW, Spiegel AM. Activity of the stimulatory guanine nucleotide-binding protein is reduced in erythrocytes from patients with pseudohypoparathyroidism and pseudopseudohypoparathyroidism: biochemical, endocrine, and genetic analysis of Albright's hereditary osteodystrophy in six kindreds. J Clin Endocrinol Metab 1986;62: 497-502
9. Koch T, Lehnhardt E, Bottinger H et al. Sensorineural hearing loss owing to deficient G proteins in patients with pseudohypoparathyroidism: results of a multicentre study. Eur J Clin Invest 1990;20:416-21
10. Patten JL, Johns DR, Valle D et al. Mutations in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy. N Engl J Med 1990;322:1412-8
11. Weinstein LS, Gejman PV, Friedman E et al. Mutations of the Gs alpha subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis. Proc Natl Acad Sci USA 1990;87:8287-90
12. Miric A, Vechio JD, Levine MA. Heterogeneous mutations in the gene encoding the alpha-subunit of the stimulatory G protein of adenylyl cyclase in Albright hereditary osteodystrophy. J Clin Endocrinol Metab 1993;76:1560-8
13. Weinstein LS, Gejman PV, de Mazancourt P, American N, Spiegel AM. A heterozygous 4-bp deletion mutation in the Gs alpha gene (GNAS1) in a patient with Albright hereditary osteodystrophy. Genomics 1992;13:1319-21
14. Lin CK, Hakakha MJ, Nakamoto JM et al. Prevalence of three mutations in the Gs alpha gene among 24 families with pseudohypoparathyroidism type Ia. Biochem Biophys Res Commun 1992;189:343-9
15. Luttikhuis ME, Wilson LC, Leonard JV, Trembath RC. Characterization of a de novo 43-bp deletion of the Gs alpha gene (GNAS1) in Albright hereditary osteodystrophy. Genomics 1994;21:455-7
16. Schwindinger WF, Miric A, Zimmerman D, Levine MA. A novel Gs alpha mutant in a patient with Albright hereditary osteodystrophy uncouples cell surface receptors from adenylyl cyclase. J Biol Chem 1994;269:25387-91
17. Farfel Z, Iiri T, Shapira H, Roitman A, Mouallem M, Bourne HR. Pseudohypoparathyroidism, a novel mutation in the betagammacontact region of Gs alpha impairs receptor stimulation. J Biol Chem 1996;271:19653-5
18. Iiri T, Herzmark P, Nakamoto JM, Van Dop C, Bourne HR. Rapid GDP release from Gs alpha in patients with gain and loss of endocrine function. Nature 1994;371:164-8
19. Davies SJ, Hughes HE. Imprinting in Albright's hereditary osteodystrophy. J Med Genet 1993;30:101-3
20. Wilson LC, Oude Luttikhuis ME, Clayton PT, Fraser WD, Trembath RC. Parental origin of Gs alpha gene mutations in Albright's hereditary osteodystrophy. J Med Genet 1994;31:835-9
21. Campbell R, Gosden CM, Bonthron DT. Parental origin of transcription from the human GNAS1 gene. J Med Genet 1994;31: 607-14
22. Carel JC, Mallet E, Garabédian M. Maladies endocriniennes de l'enfant dues à des défauts génétiques des protéines G ou des récepteurs couplés aux protéines G. Journées Parisiennes de Pédiatrie. Paris : Flammarion : 1994,59-69
23. Schipani E, Weinstein LS, Bergwitz C et al. Pseudohypoparathyroidism type Ib is not caused by mutations in the coding exons of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene. J Clin Endocrinol Metab 1995;80:1611-21
24. Silve C, Suarez F, El Hessni A, Loiseau A, Graulet AM, Gueris J. The resistance to parathyroid hormone of fibroblasts from some patients with type Ib pseudohypoparathyroidism is reversible with dexamethasone. J Clin Endocrinol Metab 1990;71:631-8
25. Suarez F, Lebrun JJ, Lecossier D, Escoubet B, Coureau C, Silve C. Expression and modulation of the parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acid in skin fibroblasts from patients with type Ib pseudohypoparathyroidism. J Clin Endocrinol Metab 1995;80:965-70
26. Barren D, Breslau NA, Wax MB, Molinoff PB, Downs RW. New form of pseudohypoparathyroidism with abnormal catalytic adenylate cyclase. Am J Physiol 1989;257:E277-83
27. Mallet E, Carayon P, Amr S et al. Coupling defects of the thyrotropin receptor and adenylate cyclase in a pseudohypoparathyroid patient. J Clin Endocrinol Metab 1982;54:1028-32
28. Yokoro S, Matsuo M, Ohtsuka T, Ohzeki T. Hyperthyrotropinemia in a neonate with normal thyroid hormone levels: the earliest diagnostic clue for pseudohypoparathyroidism. Biol Neonate 1990;58:69-72
29. de Roux N, Misrahi M, Brauner R et al. Four families with loss of function mutations of the TSH receptor. J Clin Endocrinol Metab 1996;1:4229-35
30. Goadsby PJ, Lollin Y, Kocen RS. Pseudopseudohypoparathyroidism and spinal cord compression. J Neurol Neurosurg Psychiatry 1991;54:929-31
31. Coutant R, Carel JC, Lesage C, Rénier D, Garabédian M, Chaussain JL. Révélation d'une pseudohypoparathyroïdie par une craniosténose. Arch Pédiatr 1997 (sous presse)
32. Wilson LC, Leverton K, Luttikhuis ME et al. Brachydactyly and mental retardation: an Albrightosteodystrophy-like syndrome localized to 2q37. Am J Hum Genet 1995;56:400-7
33. Kruse K, Kracht U, Wohlfart K, Kruse U. Biochemical markers of bone turnover, intact serum parathyroid hormone and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment. Eur J Pediatr 1989;148:535-9
34. Murray TM, Rao LG, Wong MM et al. Pseudohypoparathyroidism with osteitis fibrosa cystica: direct demonstration of skeletal responsiveness to parathyroid hormone in cells cultured from bone. J Bone Miner Res 1993;8:83-91
35. Ish-Shalom S, Rao LG, Levine MA et al. Normal parathyroid hormone responsiveness of bone-derived cells from a patient with pseudohypoparathyroidism. J Bone Miner Res 1996;11:8-14